Dr. Shore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1260 silas deane hwy
Wethersfield, CT 06109Phone+1 860-547-1876Fax+1 860-520-1379- Is this information wrong?
Summary
- Dr. Eric Shore is a pulmonologist in Hartford, CT and is affiliated with Hartford Hospital. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 40 years. He specializes in asthma & copd, interstitial lung diseases, and thoracic oncology and is experienced in critical care medicine. He has more than 30 publications and over 500 citings.
Education & Training
- Temple University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1983 - 1984
- Temple University HospitalResidency, Internal Medicine, 1977 - 1981
- Perelman School of Medicine at the University of PennsylvaniaClass of 1977
Certifications & Licensure
- CT State Medical License 1984 - 2024
- PA State Medical License 1979 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014-2021
- quality and safety award Hartford hospital Board of Directors, 2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
- Join now to see all
Publications & Presentations
PubMed
- The High (Personal) Cost of Critical Care Medicine.Eric Shore> ;Connecticut Medicine. 2016 Sep 1
- 32 citationsTreatment of multidrug-resistant Pseudomonas aeruginosa with ceftolozane/tazobactam in a critically ill patient receiving continuous venovenous haemodiafiltrationJoseph L. Kuti, Islam M. Ghazi, Richard Quintiliani, Eric Shore, David P. Nicolau> ;International Journal of Antimicrobial Agents. 2016 Sep 1
- 73 citationsPhase I, open-label, safety and pharmacokinetic study to assess bronchopulmonary disposition of intravenous eravacycline in healthy men and women.Kevin P. Connors, Seth T. Housman, J. Samuel Pope, John Russomanno, Edward Salerno, Eric Shore, Susan Redican, David P. Nicolau> ;Antimicrobial Agents and Chemotherapy. 2014 Apr 1
- Join now to see all
Hospital Affiliations
- Hartford HospitalHartford, Connecticut
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: